India Extends Grants To Drug Makers For Neglected Diseases
This article was originally published in PharmAsia News
Executive Summary
A Cabinet committee of the Indian government approved a provision to extend grants to drug makers to encourage development of drugs for neglected diseases. The grants would include research for treatments for malaria, tuberculosis, kala-azar, filariasis and other diseases pharma companies are generally not developing, but which are considered a threat in tropical India. Under the current plan that would be extended by the Cabinet Committee on Economic Affairs, drug makers would be eligible for soft loans for up to 70 percent of the total project cost at 3 percent interest for 10 years. (Click here for more